On Mon, Aug 16, 2010 at 1:38 PM, Judah McAuley <ju...@wiredotter.com> wrote:
> > As an aside about drug research, pharmaceutical companies only have to > publish and submit the reports they want regarding a drug. A pharma > company can do 10 studies on a drug, 9 of which show no positive > difference and 1 that does and then simply submit the 1 study that > does show a positive difference. The FDA can say "well, one study > isn't a sufficient amount" and wait for further research, but the drug > company is currently under no obligation to tell the FDA that they did > 9 other studies already that didn't back up the claims they make in > their FDA application. > > The FDA doesn't do independent clinical trails. They rely upon the > data given to them and that data is carefully selected to put the most > positive light on an application. Something to consider when you start > thinking about the process behind new drugs and the FDA. > I don't necessarily have a problem with that...let the companies spend the time and money to do the research, and then let the FDA ensure that everything is on the up and up. I'd be curious how, if...and this might be a big IF...if all 10 trials were on the up and up, why 9 would fail, and then suddenly 1 would succeed???? Shouldn't they either all corroborate, or all refute....if all proper variables are accounted for??? -- No matter how close to yours another's steps have grown In the end there is one dance you'll do alone ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~| Order the Adobe Coldfusion Anthology now! http://www.amazon.com/Adobe-Coldfusion-Anthology-Michael-Dinowitz/dp/1430272155/?tag=houseoffusion Archive: http://www.houseoffusion.com/groups/cf-community/message.cfm/messageid:325103 Subscription: http://www.houseoffusion.com/groups/cf-community/subscribe.cfm Unsubscribe: http://www.houseoffusion.com/groups/cf-community/unsubscribe.cfm
